KLF3 expression was also negatively associated with clinical stage progression in COAD, COADREAD, ESCA, KIPAN, KIRC, THCA, and OV and positively associated with a clinical stage in PAAD. Here, KLF3 is linked to pancreatic adenocarcinoma.